What You Should Know:
- After a strong start to the year, the digital health sector experienced a significant pullback in Q2 2025, with deal volume declining to its lowest quarterly activity level in the last five years, according to new report from CB Insights.
- The new CB Insights report, “State of Digital Health Q2’25” reveals the drop reflects growing investor selectivity and capital concentration in fewer, high-conviction bets amidst ongoing global economic uncertainty.
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years
What You Should Know:
- Advancements in accelerating early Alzheimer’s disease (AD) screening and access to care, proven from three diverse community pilot initiatives, were presented today during a podium presentation at the Alzheimer’s Association International Conference® 2025 (AAIC). The study, entitled “Remote Collection of Biomarkers for Alzheimer’s Disease and Related Disorders,” validated Neurogen’s new ecosystem, which brings together the first in-home blood biomarker testing
Read More
Breaking the Silence: Using AI to Empower Men to Seek Help for Mental Health
In a world where strength is often measured by stoicism, millions of men are suffering in silence. The statistics around male suicide paint a sobering picture: men die by suicide at nearly four times the rate of women, making it one of the leading causes of death among men — particularly those in their middle years.
Despite this alarming reality, less than half of men experiencing depression, anxiety, or other mental health conditions will ever seek professional help. The
Read More
CaringAI Launches AI-Powered Dementia Platform, Appoints Dr. Stephanie Ruth Young as Clinical Research Advisor
What You Should Know:
- CaringAI, a healthcare AI company focused on advancing how dementia is detected and managed, announced its official launch alongside the appointment of Dr. Stephanie Ruth Young, M.Ed., Ph.D., as Clinical Research Advisor.
- CaringAI’s first product, a phone-optimized cognitive screening and care planning platform, uses speech-based AI to overcome barriers for clinicians, caregivers, and millions of older adults at risk for cognitive decline.
- Dr.
Read More
Scopio Labs Unveils First-of-Its-Kind AI-Powered Solution to Fully Automate Blood Morphology
What You Should Know:
- Scopio Labs, developer of Full-Field Cell Morphology imaging and analysis platform, announced today the unveiling of its groundbreaking Complete Blood Morphology (CBM®) analyzer. CBM will bring unprecedented scale, efficiency and standardization to hematology through autonomous morphology analysis and reporting, one of the last remaining manual processes in diagnostics.
- To expedite the go-to-market of CBM®, Viola Growth has joined as a new investor with a $10
Read More
The Rise of AI in Medical Credentialing
With healthcare systems struggling with staff shortages and complex care demands all over the world, artificial intelligence has become a powerful tool to certify the professional competencies and credentials of all kinds of medical professionals.
The best part of this is that it’s quick, accurate, and scalable. This is an evolving subset of AI in human resources and healthcare management, named “algorithmic credentialing”. With this tool, hospitals, clinics, and academic institutions
Read More
Trinity Biotech Unveils CGM+: AI-Native Wearable Biosensor for Holistic Health Monitoring
What You Should Know:
- Trinity Biotech, a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today unveiled its new flagship product, CGM+, a next-generation wearable biosensor platform designed for the $260 billion AI wearables market.
- Now in the later stages of device development, CGM+ is Trinity’s new AI-native continuous glucose monitoring (CGM) system, combining multi-sensor data and real-time analytics to meet the
Read More
MIT Launches New Clinical Trial Using Ultrasound to Study Human Consciousness
What You Should Know:
- Openwater, an open-source medical technology company delivering portable, hospital-grade diagnostic and therapeutic devices, today announced that the Massachusetts Institute of Technology’s (MIT) Lincoln Laboratory is the first to receive the latest version of the company’s Open-LIFU device.
- The deployment marks a major milestone for Openwater and significantly expands access to low-intensity focused ultrasound (LIFU) for clinical and academic
Read More
Plexision Secures Investment to Accelerate AI in Transplant Diagnostics
What You Should Know:
- Plexision, a biotechnology company, today announced a $365k investment from the Richard King Mellon Foundation. The funds will be used to accelerate the integration of artificial intelligence (AI) and machine learning (ML) capabilities across Plexision’s suite of cell-based blood tests, significantly improving predictive accuracy for complex transplant outcomes.
Despite advances in transplant medicine, managing immunosuppressive drugs remains a delicate
Read More
Slingshot AI Launches Ash: The First AI Designed for Therapy
What You Should Know:
- Slingshot AI announced the public launch of Ash, the first AI designed for therapy, alongside an extension of its Series A funding round. Co-led by Radical Ventures and Forerunner Ventures, this brings the total capital raised to $93M, with previous investors a16z, Felicis, and Menlo also participating.
- After 18 months of development and testing with 50,000 beta users, Ash is now available as a free iOS and Android app, offering deeply personalized mental
Read More
